The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Joseph, A. M.
Right arrow Articles by Thorley-Lawson, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Joseph, A. M.
Right arrow Articles by Thorley-Lawson, D. A.
The Journal of Immunology, 00, 165: 2975-2981.
Copyright © 00 by The American Association of Immunologists

EBV Persistence Involves Strict Selection of Latently Infected B Cells1

Alexandra M. Joseph, Gregory J. Babcock and David A. Thorley-Lawson2

Tufts University School of Medicine, Boston, MA 02138

EBV is found preferentially in IgD- B cells in the peripheral blood. This has led to the proposal that the recirculating memory B cell pool is the site of long-lived persistent infection. In this paper we have used CD27, a newly identified specific marker for memory B cells, to test this hypothesis. We show that EBV is tightly restricted in its expression. Less than 1 in 1000 of the infected cells in the peripheral blood are naive (IgD+, CD27-) and <1 in 250 are IgD+ memory cells. Furthermore, EBV was undetectable in the self-renewing peripheral CD5+ or B1 cells, a subset that has not been through a germinal center. No such restriction was observed in tonsillar B cells. Therefore, the virus has access to a range of B cell subsets in the lymph nodes but is tightly restricted to a specific long-lived compartment of B cells, the IgD-, CD27+, and CD5- memory B cells, in the periphery. We suggest that access to this compartment is essential to allow the growth-promoting latent genes to be switched off to create a site of persistent infection that is neither pathogenic nor a target for immunosurveillance.




This article has been cited by other articles:


Home page
BloodHome page
S. Chaganti, E. M. Heath, W. Bergler, M. Kuo, M. Buettner, G. Niedobitek, A. B. Rickinson, and A. I. Bell
Epstein-Barr virus colonization of tonsillar and peripheral blood B-cell subsets in primary infection and persistence
Blood, June 18, 2009; 113(25): 6372 - 6381.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. T. Garnett, G. Talekar, J. A. Mahr, W. Huang, Y. Zhang, D. A. Ornelles, and L. R. Gooding
Latent Species C Adenoviruses in Human Tonsil Tissues
J. Virol., March 15, 2009; 83(6): 2417 - 2428.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Cocco, C. Bellan, R. Tussiwand, D. Corti, E. Traggiai, S. Lazzi, S. Mannucci, L. Bronz, N. Palummo, C. Ginanneschi, et al.
CD34+ Cord Blood Cell-Transplanted Rag2-/- {gamma}c-/- Mice as a Model for Epstein-Barr Virus Infection
Am. J. Pathol., November 1, 2008; 173(5): 1369 - 1378.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Rovedo and R. Longnecker
Epstein-Barr Virus Latent Membrane Protein 2A Preferentially Signals through the Src Family Kinase Lyn
J. Virol., September 1, 2008; 82(17): 8520 - 8528.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Chaganti, C. S. Ma, A. I. Bell, D. Croom-Carter, A. D. Hislop, S. G. Tangye, and A. B. Rickinson
Epstein-Barr virus persistence in the absence of conventional memory B cells: IgM+IgD+CD27+ B cells harbor the virus in X-linked lymphoproliferative disease patients
Blood, August 1, 2008; 112(3): 672 - 679.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Dorner, F. Zucol, C. Berger, R. Byland, G. T. Melroe, M. Bernasconi, R. F. Speck, and D. Nadal
Distinct Ex Vivo Susceptibility of B-Cell Subsets to Epstein-Barr Virus Infection According to Differentiation Status and Tissue Origin
J. Virol., May 1, 2008; 82(9): 4400 - 4412.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. A. Souza, B. D. Stollar, J. L. Sullivan, K. Luzuriaga, and D. A. Thorley-Lawson
Influence of EBV on the Peripheral Blood Memory B Cell Compartment
J. Immunol., September 1, 2007; 179(5): 3153 - 3160.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C.-C. Lu, H.-T. Huang, J.-T. Wang, G. Slupphaug, T.-K. Li, M.-C. Wu, Y.-C. Chen, C.-P. Lee, and M.-R. Chen
Characterization of the Uracil-DNA Glycosylase Activity of Epstein-Barr Virus BKRF3 and Its Role in Lytic Viral DNA Replication
J. Virol., February 1, 2007; 81(3): 1195 - 1208.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I.-J. Kim, C. E. Burkum, T. Cookenham, P. L. Schwartzberg, D. L. Woodland, and M. A. Blackman
Perturbation of B Cell Activation in SLAM-Associated Protein-Deficient Mice Is Associated with Changes in Gammaherpesvirus Latency Reservoirs
J. Immunol., February 1, 2007; 178(3): 1692 - 1701.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Rovedo and R. Longnecker
Epstein-Barr Virus Latent Membrane Protein 2B (LMP2B) Modulates LMP2A Activity
J. Virol., January 1, 2007; 81(1): 84 - 94.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Tobollik, L. Meyer, M. Buettner, S. Klemmer, B. Kempkes, E. Kremmer, G. Niedobitek, and B. Jungnickel
Epstein-Barr virus nuclear antigen 2 inhibits AID expression during EBV-driven B-cell growth
Blood, December 1, 2006; 108(12): 3859 - 3864.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Le Clorennec, I. Youlyouz-Marfak, E. Adriaenssens, J. Coll, G. W. Bornkamm, and J. Feuillard
EBV latency III immortalization program sensitizes B cells to induction of CD95-mediated apoptosis via LMP1: role of NF-{kappa}B, STAT1, and p53
Blood, March 1, 2006; 107(5): 2070 - 2078.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. D. Allen III, S. Dickerson, and S. H. Speck
Identification of Spliced Gammaherpesvirus 68 LANA and v-Cyclin Transcripts and Analysis of Their Expression In Vivo during Latent Infection
J. Virol., February 15, 2006; 80(4): 2055 - 2062.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. A. Souza, B. D. Stollar, J. L. Sullivan, K. Luzuriaga, and D. A. Thorley-Lawson
Peripheral B cells latently infected with Epstein-Barr virus display molecular hallmarks of classical antigen-selected memory B cells
PNAS, December 13, 2005; 102(50): 18093 - 18098.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Conacher, R. Callard, K. McAulay, H. Chapel, D. Webster, D. Kumararatne, A. Chandra, G. Spickett, P. A. Hopwood, and D. H. Crawford
Epstein-Barr Virus Can Establish Infection in the Absence of a Classical Memory B-Cell Population
J. Virol., September 1, 2005; 79(17): 11128 - 11134.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. J. Gross, D. Hochberg, W. M. Rand, and D. A. Thorley-Lawson
EBV and Systemic Lupus Erythematosus: A New Perspective
J. Immunol., June 1, 2005; 174(11): 6599 - 6607.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. O. Willer and S. H. Speck
Establishment and Maintenance of Long-Term Murine Gammaherpesvirus 68 Latency in B Cells in the Absence of CD40
J. Virol., March 1, 2005; 79(5): 2891 - 2899.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
L. L. Laichalk and D. A. Thorley-Lawson
Terminal Differentiation into Plasma Cells Initiates the Replicative Cycle of Epstein-Barr Virus In Vivo
J. Virol., January 15, 2005; 79(2): 1296 - 1307.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
E. Schauer, S. Webber, M. Green, and D. Rowe
Surface Immunoglobulin-Deficient Epstein-Barr Virus-Infected B Cells in the Peripheral Blood of Pediatric Solid-Organ Transplant Recipients
J. Clin. Microbiol., December 1, 2004; 42(12): 5802 - 5810.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. Hochberg, T. Souza, M. Catalina, J. L. Sullivan, K. Luzuriaga, and D. A. Thorley-Lawson
Acute Infection with Epstein-Barr Virus Targets and Overwhelms the Peripheral Memory B-Cell Compartment with Resting, Latently Infected Cells
J. Virol., May 15, 2004; 78(10): 5194 - 5204.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Ikeda, M. Merchant, L. Lev, R. Longnecker, and M. Ikeda
Latent Membrane Protein 2A, a Viral B Cell Receptor Homologue, Induces CD5+ B-1 Cell Development
J. Immunol., May 1, 2004; 172(9): 5329 - 5337.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
D. A. Thorley-Lawson and A. Gross
Persistence of the Epstein-Barr Virus and the Origins of Associated Lymphomas
N. Engl. J. Med., March 25, 2004; 350(13): 1328 - 1337.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. Hochberg, J. M. Middeldorp, M. Catalina, J. L. Sullivan, K. Luzuriaga, and D. A. Thorley-Lawson
Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo
PNAS, January 6, 2004; 101(1): 239 - 244.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. Lieby, A. Soley, A.-M. Knapp, M. Cerutti, J.-M. Freyssinet, J.-L. Pasquali, and T. Martin
Memory B cells producing somatically mutated antiphospholipid antibodies are present in healthy individuals
Blood, October 1, 2003; 102(7): 2459 - 2465.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. O. Willer and S. H. Speck
Long-Term Latent Murine Gammaherpesvirus 68 Infection Is Preferentially Found within the Surface Immunoglobulin D-Negative Subset of Splenic B Cells In Vivo
J. Virol., August 1, 2003; 77(15): 8310 - 8321.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I.-J. Kim, E. Flano, D. L. Woodland, F. E. Lund, T. D. Randall, and M. A. Blackman
Maintenance of Long Term {gamma}-Herpesvirus B Cell Latency Is Dependent on CD40-Mediated Development of Memory B Cells
J. Immunol., July 15, 2003; 171(2): 886 - 892.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Flano, I.-J. Kim, J. Moore, D. L. Woodland, and M. A. Blackman
Differential {gamma}-Herpesvirus Distribution in Distinct Anatomical Locations and Cell Subsets During Persistent Infection in Mice
J. Immunol., April 1, 2003; 170(7): 3828 - 3834.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
E. Flano, I.-J. Kim, D. L. Woodland, and M. A. Blackman
{gamma}-Herpesvirus Latency Is Preferentially Maintained in Splenic Germinal Center and Memory B Cells
J. Exp. Med., November 18, 2002; 196(10): 1363 - 1372.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
C. Rose, M. Green, S. Webber, L. Kingsley, R. Day, S. Watkins, J. Reyes, and D. Rowe
Detection of Epstein-Barr Virus Genomes in Peripheral Blood B Cells from Solid-Organ Transplant Recipients by Fluorescence In Situ Hybridization
J. Clin. Microbiol., July 1, 2002; 40(7): 2533 - 2544.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Nikiforow, K. Bottomly, and G. Miller
CD4+ T-Cell Effectors Inhibit Epstein-Barr Virus-Induced B-Cell Proliferation
J. Virol., April 15, 2001; 75(8): 3740 - 3752.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. J. Babcock and D. A. Thorley-Lawson
Tonsillar memory B cells, latently infected with Epstein-Barr virus, express the restricted pattern of latent genes previously found only in Epstein-Barr virus-associated tumors
PNAS, October 24, 2000; 97(22): 12250 - 12255.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.